Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Kymera Therapeutics (KYMR) Preferred Shares Issued (2019 - 2020)

Kymera Therapeutics (KYMR) has disclosed Preferred Shares Issued for 2 consecutive years, with $83.4 million as the latest value for Q4 2020.

  • On a quarterly basis, Preferred Shares Issued rose 1064.86% to $83.4 million in Q4 2020 year-over-year; TTM through Dec 2020 was $88.2 million, a N/A change, with the full-year FY2020 number at $88.2 million, up 316.28% from a year prior.
  • Preferred Shares Issued was $83.4 million for Q4 2020 at Kymera Therapeutics, up from -$83.4 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $88.2 million in Q1 2020 to a low of -$83.4 million in Q2 2020.